P450-GENES - EVOLUTION, REGULATION, AND RELATIONSHIP TO HUMAN CANCER AND PHARMACOGENETICS

被引：44
作者：
GONZALEZ, FJ [1 ]
JAISWAL, AK [1 ]
NEBERT, DW [1 ]
机构：
[1] NICHHD,DEV PHARMACOL LAB,BETHESDA,MD 20892
来源：
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY | 1986年 / 51卷
关键词：
D O I：
10.1101/SQB.1986.051.01.101
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：879 / 890
页数：12
相关论文
共 58 条
[31]  
KALOW W, 1962, PHARMACOGENETICS HER, P146
[32]   ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY AND BRONCHOGENIC CARCINOMA [J].
KELLERMANN, G ;
SHAW, CR ;
LUYTENKE.M .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (18) :934-937
[33]  
KOURI RE, 1982, CANCER RES, V42, P5030
[34]  
KOURI RE, 1977, ORIGINS HUMAN CANCER, V4, P811
[35]   CLINICAL-PHARMACOLOGY - POSSIBLE CLINICAL IMPORTANCE OF GENETIC-DIFFERENCES IN DRUG-METABOLISM [J].
NEBERT, DW .
BMJ-BRITISH MEDICAL JOURNAL, 1981, 283 (6290) :537-542
[36]   THE AH LOCUS, A MULTIGENE FAMILY NECESSARY FOR SURVIVAL IN A CHEMICALLY ADVERSE ENVIRONMENT - COMPARISON WITH THE IMMUNE-SYSTEM [J].
NEBERT, DW ;
NEGISHI, M ;
LANG, MA ;
HJELMELAND, LM ;
EISEN, HJ .
ADVANCES IN GENETICS, 1982, 21 :1-52
[37]   THE AH RECEPTOR - BINDING-SPECIFICITY ONLY FOR FOREIGN CHEMICALS [J].
NEBERT, DW ;
EISEN, HJ ;
HANKINSON, O .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (06) :917-924
[38]   GENETIC EXPRESSION OF ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY IN MOUSE [J].
NEBERT, DW ;
ROBINSON, JR ;
NIWA, A ;
KUMAKI, K ;
POLAND, AP .
JOURNAL OF CELLULAR PHYSIOLOGY, 1975, 85 (02) :393-414
[39]   MULTIPLE FORMS OF INDUCIBLE DRUG-METABOLIZING-ENZYMES - REASONABLE MECHANISM BY WHICH ANY ORGANISM CAN COPE WITH ADVERSITY [J].
NEBERT, DW .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1979, 27 (01) :27-46
[40]   GENETIC-DIFFERENCES IN SUSCEPTIBILITY TO CHEMICALLY-INDUCED MYELOTOXICITY AND LEUKEMIA [J].
NEBERT, DW .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1981, 39 (JUN) :11-22
123456